Dianthus Therapeutics
DNTH
DNTH
39 hedge funds and large institutions have $107M invested in Dianthus Therapeutics in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
22% less capital invested
Capital invested by funds: $136M → $107M (-$29.8M)
Holders
39
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$770K | |
| 2 | +$425K | |
| 3 | +$353K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$298K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$278K |
Top Sellers
| 1 | -$1.44M | |
| 2 | -$909K | |
| 3 | -$105K | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$87.7K |
| 5 |
RC
RBF Capital
San Francisco,
California
|
-$50.9K |